Control of SIV rebound through structured treatment interruptions during early infection

F. Lori, M. G. Lewis, J. Xu, G. Varga, Jr Zinn D.E., C. Crabbs, W. Wagner, J. Greenhouse, P. Silvera, J. Yalley-Ogunro, C. Tinelli, J. Lisziewicz

Research output: Contribution to journalArticlepeer-review


In a randomized controlled trial with acute simian immunodeficiency virus (SIV)-infected macaques, both highly active antiretroviral therapy (HAART) and HAART with fixed-schedule structured treatment interruption (STI-HAART; alternating 3 weeks on and 3 weeks off therapy) suppressed viral load. In the STI-HAART group, T cell virus-specific immune response (VIR) and control of viral rebound increased concurrently during subsequent interruptions. In contrast, VIR did not increase and SlY rebounded after permanent treatment withdrawal in all animals on continuous HAART. Fixed-schedule STI-HAART appears to be an effective alternative to continuous HAART for the early treatment of retroviral infection.

Original languageEnglish
Pages (from-to)1591-1593
Number of pages3
Issue number5496
Publication statusPublished - Nov 24 2000

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Control of SIV rebound through structured treatment interruptions during early infection'. Together they form a unique fingerprint.

Cite this